|
30/10/2024
|
Earnings brief: "3Q24: Results meet INVX, miss market" – Outperform (TP Bt38)
|
|
10/10/2024
|
Company update: "Preview 3Q24: Short-term hiccup" – Outperform (TP Bt38)
|
|
19/09/2024
|
Company update: "Target EBITDA growth with high margin products" – Outperform (TP Bt40)
|
|
24/07/2024
|
Earnings brief: "2Q24: Results in line, ready to grow in 2H24" – Outperform (TP Bt40)
|
|
10/07/2024
|
Company update: "Preview 2Q24: Down QoQ but up YoY" – Outperform (TP Bt40)
|
|
24/04/2024
|
Earnings brief: "1Q24: Beat INVX and consensus" – Outperform (TP Bt40)
|
|
10/04/2024
|
High conviction: "1Q24 to see improvement QoQ & YoY" – Outperform (TP Bt40)
|
|
13/03/2024
|
High conviction: "Clear signs of recovery" – Outperform (TP Bt40)
|
|
24/01/2024
|
Earnings brief: "4Q23: Misses INVX & consensus" – Outperform (TP Bt51)
|
|
10/01/2024
|
Company update: "4Q23: Expect earnings to improve QoQ" – Outperform (TP Bt51)
|
| |
|
| |
|
FOLLOW US
SCB's Facbook INVX's Twitter